Hangzhou Tigermed Consulting Co., Ltd.
HNGZY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3,444 | $24,953 | $25,277 | $25,166 |
| - Cash | $232 | $1,733 | $1,505 | $2,055 |
| + Debt | $246 | $2,381 | $2,855 | $2,635 |
| Enterprise Value | $3,459 | $25,601 | $26,627 | $25,746 |
| Revenue | $248 | $1,686 | $1,564 | $1,536 |
| % Growth | -85.3% | 7.8% | 1.9% | – |
| Gross Profit | $68 | $508 | $470 | $272 |
| % Margin | 27.5% | 30.1% | 30% | 17.7% |
| EBITDA | $111 | $310 | $187 | -$288 |
| % Margin | 44.7% | 18.4% | 12% | -18.8% |
| Net Income | $89 | $218 | $165 | -$408 |
| % Margin | 35.9% | 12.9% | 10.6% | -26.6% |
| EPS Diluted | 0.1 | 0.25 | 0.19 | -0.47 |
| % Growth | -60% | 31.6% | 140.4% | – |
| Operating Cash Flow | $66 | $211 | $198 | $0 |
| Capital Expenditures | -$10 | -$53 | -$48 | -$78 |
| Free Cash Flow | $56 | $158 | $150 | $440 |